Overview
Wei Cui is a Hematologist and an Oncologist in Kansas City, Kansas. Dr. Cui is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Pleuropulmonary Blastoma, and Acute Myeloblastic Leukemia with Maturation. Dr. Cui is currently accepting new patients.
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
4000 Cambridge St, Kansas City, KS 66160
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Kansas Hospital Authority
Anup Kasi-Loknath is a Hematologist Oncology specialist and an Oncologist in Westwood, Kansas. Dr. Kasi-Loknath is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer. Dr. Kasi-Loknath is currently accepting new patients.
Midwest Oncology Associates LLC
Kristopher Lybarger is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Kansas City, Missouri. Dr. Lybarger is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lump in the Abdomen, Endometrial Cancer, Vulvar Cancer, Hysterectomy, and Hernia Surgery. Dr. Lybarger is currently accepting new patients.
University Of Kansas Hospital Authority
Raed Alrajabi is a Hematologist and an Oncologist in Kansas City, Kansas. Dr. Alrajabi is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Fibrolamellar Carcinoma, Neuroendocrine Tumor, Familial Colorectal Cancer, and Familial Pancreatic Cancer. Dr. Alrajabi is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Cui isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid Leukemia
- Myelodysplastic Syndrome (MDS)
- Pleuropulmonary BlastomaDr. Cui isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Cui isExperienced. Learn about Anemia.
- B-Cell LymphomaDr. Cui isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Cui isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)